Neuroprotection by the 2-Adrenoceptor Agonist, Dexmedetomidine, in Experimental Stroke Models

Publisher： Bentham Science Publishers

E-ISSN： 1875-5844|1|2|117-122

ISSN： 1567-2700

Source： Vascular Disease Prevention, Vol.1, Iss.2, 2004-07, pp. : 117-122

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neuroprotection and Stroke

By  

Cerebrovascular Diseases, Vol. 10, Iss. 4, 2000-10 ,pp. : 21-23

Karger

Access to resources Recommend Favorite

Reconstituted High-Density Lipoprotein Exhibits Neuroprotection in Two Rat Models of Stroke

By  

Cerebrovascular Diseases, Vol. 17, Iss. 2-3, 2003-12 ,pp. : 204-211

Karger

Access to resources Recommend Favorite

Neurorepair versus Neuroprotection in Stroke

By  

Cerebrovascular Diseases, Vol. 21, Iss. 2, 2006-05 ,pp. : 54-63

Karger

Access to resources Recommend Favorite

Neuroprotection as Initial Therapy in Acute Stroke

By  

Cerebrovascular Diseases, Vol. 8, Iss. 1, 1998-01 ,pp. : 59-72

Karger

Access to resources Recommend Favorite

Inhaled Glucocorticosteroid and Long-Acting β2-Adrenoceptor Agonist Single-Inhaler Combination for Both Maintenance and Rescue Therapy: A Paradigm Shift in Asthma Management

By D'Urzo Anthony D.  

Treatments in Respiratory Medicine, Vol. 5, Iss. 6, 2006-01 ,pp. : 385-391

Adis International

Access to resources Recommend Favorite